Jane Wasman
CIK 1352455 · President, Intl and GC · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.33M
Companies
4
Total Filings
87
Lifetime Open-Market Net
-$7.66M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | Director | 18,250 | $32.85 | $599.5K | $0 | 9 | 2026-05-19 |
| SLS | Director | 92,900 | $7.83 | $727.4K | $33.8K | 11 | 2026-01-09 |
| ATHERSYS, INC / NEW (ATHX) Delisted | Director | 35,141 | $0.01 | $474 | $0 | 4 | 2023-01-11 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | President, Intl and GC | 117,420 | $0.66 | $77.6K | -$7.69M | 63 | 2019-12-04 |
Recent Filings · Page 4 of 9
87 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-13 | SLS | Grant (A) | — | $0 | EDGAR |
| 2018-03-15 | SLS | Grant (A) | — | $0 | EDGAR |
| 2018-03-12 | Acorda Therapeutics, Inc. (ACOR) Delisted | Tax (F) | −2,470 | -$63.4K | EDGAR |
| 2018-03-07 | Acorda Therapeutics, Inc. (ACOR) Delisted | Mixed | +706 | $24 | EDGAR |
| 2018-02-26 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +6,463 | $0 | EDGAR |
| 2018-01-23 | Acorda Therapeutics, Inc. (ACOR) Delisted | Mixed | — | -$268.5K | EDGAR |
| 2017-12-05 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −4,564 | -$93.7K | EDGAR |
| 2017-03-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2017-02-13 | Acorda Therapeutics, Inc. (ACOR) Delisted | Mixed | — | -$9.3K | EDGAR |
| 2016-12-05 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −3,347 | -$69.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.